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doi:10.1016/j.jfma.2011.11.023Granulomas that consist of focal accumulations of macrophages are commonly found in the
liver due to stimulation of the immune system by a number of agents. Manifestations are vari-
able depending on whether the underlying cause is a systemic disease or a primary hepatic
granulomatous reaction. This article describes the common causes, presentation, histopa-
thology, and manifestations of granulomatous diseases as well as various diagnostic and
management strategies.
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Granulomas are aggregates of modified macrophages
(epithelioid cells) and other inflammatory cells that accu-
mulate after chronic exposure to antigens. The underlying
trigger may be exposure to noxious agents that cannot be
biochemically degraded or to immune dysfunction. The
ultimate result is a release of a variety cytokines that
stimulate mononuclear cells that fuse to form multinucle-
ated giant cells with a surrounding rim of lymphocytes and
fibroblasts. The extent of inflammation associated with
granuloma formation is variable. Hepatic granulomas may
be accompanied by severe inflammation within ort of Medicine, Division of
sity of Connecticut Health
0, USA.
(G.Y. Wu).
ight ª 2012, Elsevier Taiwan LLCsurrounding granulomatous structures which is termed
granulomatous hepatitis (Fig. 1A). In other cases, there may
be little or no accompanying inflammation in which the
granulomas are referred to as bland granulomas. The term
“granulomatoid reaction” is used to describe poorly delin-
eated granulomas.1
From clinical studies, the prevalence of granulomas
ranges from 2.4%e15% of all liver biopsy specimens.2e10
Conn and others10 reported that 66% of their cases of
granulomatous reaction were secondary to a systemic
disease, 28% to primary liver disorders, and 6% were idio-
pathic. Sartin and colleagues4 reported that follow-up of
patients may reveal the cause in additional 10%e15% of the
cases indicating the importance of long-term follow-up in
determining a cause. The frequency has been reported to
be higher in specific groups such as patients with fever of
unknown origin or those infected with HIV where granu-
lomas are noted to be between 16%e75%.11 In the United
States, however, 75% of cases are a result of sarcoidosis,& Formosan Medical Association. All rights reserved.
Figure 1 (A) Granulomatous hepatitis. Note the primarily
lobular distribution and a generous lymphocytic cuff (arrow; H
and E, 40); (B) lipogranuloma. Note the fat vacuoles (arrow;
H and E, 400); (C) Note the Mycobacterium tuberculosis
bacilli (arrow; Fite acid-fast stain, 1000).
Figure 2 An epithelioid granuloma (arrow; H and E, 400).
4 M. Coash et al.mycobacterial infection, primary biliary cirrhosis, and drug-
induced liver injury.12e15 In India, it has been reported in
retrospective analyses that tuberculosis was the most
common cause (55%) of cases. Other important causes were
leprosy, sarcoidosis, histoplasmosis, brucellosis, amebic
liver abscess, lymphoma, and malignant granuloma.16
Morphology
Granulomas are compact spherical masses of aggregated
epithelioid histiocytes measuring anywhere from 50 to300 mm. This is equivalent to 0.5e6 times the diameter of
a liver core needle biopsy.17 Often, but not always, they
contain multinucleated giant cells and are surrounded by
a cuff of lymphocytes and plasma cells (Fig. 1A). Such large
granulomas are often formed by conglomeration of smaller
ones. Four morphologic types of hepatic granulomas have
been described.18 One type is a foreign body granuloma
consisting of inclusions of particulate material within
cytoplasmic vacuoles. Examples of indigestible particulate
materials include mineral oil, starch, and silicone.18
Another type is the lipogranuloma, which is associated
with hepatic steatosis (Fig. 1B). Histiocytes and macro-
phages surround a vacuole of triglycerides. These lipo-
granulomas do not cause bile duct injury or cholestasis and
their medical significance is uncertain.13 A third type of
granuloma is an epithelioid granuloma in which there is
differentiation of activated macrophages into secretory
cells leading to synthesis and secretion of large amounts of
cytokines (Fig. 2).19 Due to the fact that there are no
inclusions within these cells, there is a homogeneous
appearance to the cytoplasm, which is the reason that this
type of granuloma acquired its epithelioid designation. The
plasma membranes of these cell types can fuse leading to
the formation of giant cells or Langhans cells. Deposition of
collagen or fibrin can occur at the periphery leading to
a fibrin-ring granuloma as is seen in Q fever, although such
granulomas are not specific for this condition.19 A fourth
type of granuloma, lymphohistiocytic granuloma, is clini-
cally similar to epithelioid granuloma. However, epithelioid
cells are not found in the accumulations of macrophages
and lymphocytes.19
The morphology of granulomas is not specific enough to
identify the cause, although it can help in developing
a differential diagnosis. For example, the presence of
necrosis or caseation points to infection with Mycobacte-
rium tuberculosis. Poorly formed granulomatous reaction
without necrosis is typical in patients with defective
immune systems such as patients with AIDS. (Fig. 3A) These
granulomas typically contain a large number of acid-fast
organisms, M avium intracellulare. The presence of
plasma cells in the lymphocytic cuff favors syphilis, while
numerous eosinophils might indicate a hypersensitivity to
medication (Figs. 4A and B) or parasitic disease. The
Figure 3 (A) Granulomatous hepatitis associated with AIDS. Note the ill-defined, nature of granulomas (arrows; H and E, 40);
(B) example of a better-defined granuloma in granulomatous hepatitis of AIDS (H and E, 400); (C) large numbers of Mycobacterium
avium intracellulare within and around loosely arranged aggregates of epithelioid histiocytes (arrow) (Fite acid fast stain, 400);
(D) clusters of acid fast bacilli (arrow; Fite acid fast stain, 1000).
Hepatic granulomatosis 5presence of a fibrin ring, a fibrin doughnut, suggests Q
fever. Well-formed granulomas with little lymphocytic cuff
and no necrosis in the portal areas with fibrosis point to
sarcoidosis (Figs. 5A and B). Foreign body granulomas often
show detectable foreign material microscopically under
normal or polarized light (Table 1 and 2).
Lipogranulomas are a specific form of granulomatous
reaction containing fat vacuoles and often no giant cells
(Fig. 2). These are associated with fatty liver disease that is
increasing in incidence and, are more common in alcoholic
fatty liver disease than other types. Because of lack of
specificity, clinical and laboratory modalities need to be
employed to determine the cause. Granulomas can often
accumulate in the liver near portal tracts, and can be
associated with elevated alkaline phosphatase.12 Cells
within the granuloma can secrete a variety of proteins and
enzymes such as lysozyme, collagenase, and angiotensin-
converting enzyme as can be seen in sarcoidosis.20 There
can also be various forms of necrosis that provide clues as
to the cause of the granulomas. These findings include
“caseating” necrosis as is found in pulmonary tuberculosis,
or “noncaseating” necrosis as can be seen in sarcoid
granulomas.13
The location of granulomas on histologic evaluation can
also be helpful as a general guide to diagnosis. For example,
in primary biliary cirrhosis (Fig. 6A) and sarcoidosis (Fig. 5A),
granulomas are observed near portal regions, whereas drug-
induced granulomas are more often poorly defined and are
found within the hepatic lobules. (Fig. 4A).13Pathogenesis
As mentioned above, granuloma formation is due to
a chronic inflammatory reaction with the presence of
epithelioid cells or giant multinucleated cells surrounded
by lymphocytes, monocytes and plasma cells.20 The term
“epithelioid histiocytes” refers to modified tissue mono-
cytes, macrophages, and histiocytes that arise from blood
monocytes. They can be considered immunologically acti-
vated histiocytes and macrophages. Their immunologic and
phagocytic activity is enhanced under the influence of T-
cell interleukins.21
Granuloma formation occurs when the humoral or
cellular immune response fails to eliminate the offending
foreign material.20 This is largely a delayed hypersensitivity
cellular immune response, which attempts to isolate and
neutralize pathogenic material and is otherwise difficult to
eradicate.
There are two main types of granulomatous reaction: (1)
a reaction to immunologically inert, large foreign bodies,
and (2) a reaction to immunologically active antigenic,
poorly degradable particles. The two types also differ in
their pathogenesis.21
The type of immune response that occurs depends on
whether the foreign particles are intra- or extracellular in
origin. The Th1 response usually targets intracellular
pathogens leading to secretion of various cytokines such as
interferon gamma, interleukin (IL)-2, and IL-12. Extracel-
lular pathogens evoke a Th2 response with the secretion of
Figure 4 (A) Granulomatous hepatitis, hypersensitivity to
medication. Notice the lobular distribution of granuloma
(arrow; H and E, 40); (B) extensive eosinophilic reaction in
the inflammatory cuff of the granuloma (arrow; H and E,
400).
6 M. Coash et al.IL-4, 5, 6, and 10. Both reactions elicit a positive feedback
response on T-cells perpetuated by cytokines. The forma-
tion and maintenance of granulomas in the liver is based on
cytokine release.13 In the immunologically active type,
granuloma formation appears to begin with phagocytosis of
immunologically active materials by ordinary macrophages.
The macrophages then process the offending agent into
simple antigenic peptides, which are then presented to T-
lymphocytes. This causes activation of T-lymphocytes,Figure 5 (A) Sarcoidosis. Note the portal distribution and exces
(B) sarcoidosis, extensive fibrosis (arrow; trichrome stain, 400).stimulating them to produce various cytokines leading to
activation of other T-cells and conversion of ordinary
histiocytes and macrophages into epithelioid histiocytes,
a more potent cell type. These epithelioid histiocytes
aggregate into a granuloma and can fuse to form giant cells.
Additionally, this granulomatous reaction is typically sur-
rounded by a cuff of lymphocytes, a few plasma cells, and
eosinophils. The makeup of this cuff is to some extent
determined by the causative agent. Epithelioid histiocytes
are capable of causing tissue necrosis leading to the so-
called “necrotizing” granulomas as is typical with infec-
tious agents.21
Accumulation of these effector cells in the portal tract
leads to injury of the septal and interlobular bile ducts that
can cause cholestasis. Potential modifiers of this inflam-
matory response are being investigated as pharmacologic
targets for therapeutic modulation of or interference with
cytokine production.13
Clinical presentation
The symptoms of granulomatous liver disease depend on
the underlying disease. Patients are frequently asymp-
tomatic, and they may not even have laboratory evidence
of hepatic dysfunction. When manifestations of granulo-
matous disorders affecting the liver do occur, they are
usually due to cytokine release by activated macrophages
and lymphocytes that may cause liver injury.22 Symptoms
such as fever, weight loss, anorexia, night sweats, and
adenopathy may be present in the case of systemic disease.
Laboratory signs of inflammation, as well as elevated
alkaline phosphatase and hepatomegaly, have been re-
ported in 60% of cases.14 Jaundice is rare unless there is bile
duct injury. Severe pain in the right upper quadrant can be
present even without biliary injury.12,14,15,23
Diagnosis of hepatic granulomatosis
A comprehensive medical history and physical examination
should be pursued along with an extensive medication and
travel history. A reasonable initial approach is to search
first for the most common causes of granulomatous liver
disease in a particular population to avoid unnecessary
testing. Asymptomatic patients are usually discovered
because of abnormal liver enzyme tests or a family orsive fibrosis around granuloma (arrow; trichrome stain, 100);
Table 1 Granuloma types and characteristics.
Granuloma types Granuloma characteristics
Foreign body Internal particulate material: mineral
oil, starch, silicone
Lipogranuloma Vacuoles of triglycerides
Epithelioid Activated macrophages that can
secrete cytokines and aggregate to
form giant cells, or Langhans cells.
Fibrin rings may form due to fibrin
deposition
Lymphohistiocytic Macrophage and lymphocyte
accumulation
Hepatic granulomatosis 7personal history of increased risk for granulomatous
disease. Symptoms may be helpful in developing a differ-
ential diagnosis. For example, if fever is present, the
investigation should focus on infectious causes or sarcoid-
osis. If there are signs of portal hypertension on physical
examination, causes such as schistosomiasis, sarcoidosis, or
primary biliary cirrhosis (PBC) may considered higher on the
list of differential diagnoses.13
Initial testing may include a chest radiography, cultures
for bacteria, mycobacteria, viruses, and fungi. Serologies
for hepatitis B, C, as well as syphilis, Q fever, and brucella
can also be pursued. Other studies including anti-
mitochondrial antibody, angiotensin-converting enzyme
levels, and a tuberculin skin test can be helpful. Although
the above tests can provide helpful clues as to the possible
existence of granulomatous liver disease, the diagnosis can
only be made by histologic examination of liver biopsies.Table 2 Granuloma etiologies and characteristics.
Granuloma etiologies Granuloma characteristics
Autoimmune
Sarcoid Noncaseating epithelioid granu
Primary biliary cirrhosis Noncaseating granulomas near
Infectious
Mycobacterium tuberculosis AFB inside epithelioid granulom
histiocytes
M avium intracellulare Aggregates of foamy macropha
M leprae Foamy histiocytes in portal tra
Brucella Noncaseating granulomas
Rickettsia Fibrin ring surrounding vesicle
Francisella Suppurative microabscesses wi
Listeria Microabscesses with small gran
Bartonella henselae Stellate abscesses with three d
Tropheryma whipplei Epithelioid granulomas
Histoplasma Macrophages and lymphocytes
Schistosoma Eosinophils with fibrosis and col
with egg at the center
Leishmania Fibrin ring or epithelioid granu
Hepatitis C Epithelioid granulomas
Drugs and Chemicals Granulomas with eosinophils
Malignancy Non-necrotic granulomas
AFB Z Acid-fast bacilli.Stains of liver biopsies for acid-fast bacilli, fungi, spiro-
chetes, and Bartonella as well as careful examination for
ova, foreign bodies, eosinophils, lipid vacuoles, and fibrin
are also important in the diagnostic work-up.24
There is no characteristic pattern of liver biochemical
abnormalities suggestive of any specific cause of granulo-
matous liver disease. Elevated alkaline phosphatase may be
more common in patients with granulomas related to
sarcoidosis or PBC or drug-induced injury due to bile
ductule involvement. However, elevated aminotransferase
levels can be found in schistosomiasis or drug-induced
hepatotoxicity.13
Imaging studies can show liver sizes that range from
normal to massive hepatomegaly. A homogenous or coarse
appearance may be noted, and calcifications can be seen
on plain radiographs. Granulomas of 0.5 cm in diameter or
greater can be detected on magnetic resonance imaging
(MRI) as multiple nodular lesions or, less commonly, isolated
hepatic granulomas. The former may have an appearance
suggesting the presence of a malignant neoplasm. Case-
ating granulomas as in tuberculosis have a high or low signal
in T1-weighted magnetic resonance images, and no
enhancement, or sometimes peripheral enhancement after
gadolinium injection in comparison to noncaseating granu-
lomas in sarcoidosis which have intermediate signals on T1-
weighted images with gadolinium enhancement that may or
may not persist on late images.25e27
Etiologies
The etiologies of granulomatous liver disease are diverse,
and they can be a result of primary liver disease or otherlomas
portal triads
as and giant cells often with ring of lymphocytes and
ges in parenchyma and portal triads with þAFB stain
cts and lobules with multiple AFB found
of fat
th surrounding macrophages
ulomas
istinct zones
with histoplasma and epithelioid cells in center
lagen deposition in peri-portal and peri-sinusoidal areas often
lomas
Figure 6 (A) Primary biliary cirrhosis. Note the significant inflammatory response and expansion of portal areas in a granulo-
matous reaction (arrows; H and E, 100); (B) note the inflammatory cells spilling over into the adjacent liver lobule resulting in an
interface hepatitis (arrow) and scarcity of bile ducts (H and E, 400).
8 M. Coash et al.systemic diseases; 13%e36% have an unclear etiology
despite extensive evaluations.12,28,29 In the Western world,
the two major causes of granulomas in liver biopsies are
sarcoidosis and tuberculosis. However, the frequency with
which other causes are found depends on the geographic
area. For instance, schistosomiasis is a frequent cause of
granulomas in areas where this parasitic infection is
endemic.13
The presence of hepatic granulomas may be an inci-
dental finding and may not require treatment. However,
many diseases can be associated with hepatic granulomas.
Primary liver diseases rarely cause hepatic granulomatous
disease except for primary biliary cirrhosis, and hepatitis C.
Tuberculosis and schistosomiasis are the most common
infectious causes of hepatic granulomatous inflammation
worldwide primarily in non-Western countries. Other
important causes include malignancy such as Hodgkin
lymphoma and drug-related injury.
It is helpful to classify the causes of granulomatous
hepatitis into several broad categories such as autoimmune
disorders, systemic infections, medications, malignancy,
idiopathic causes and, rare causes, which encompass
a broad category of systemic granulomatous diseases,
connective tissue diseases causing a systemic inflammatory
disorder, and digestive disorders.13
Autoimmune disorders
Sarcoidosis
Sarcoidosis is a granulomatous disease of unknown cause
that can affect several organs, including the liver. Although
the disease mainly affects the lungs and lymphoid tissue,
involvement of the liver can be demonstrated in 80% of
people who undergo liver biopsy. Noncaseating epithelioid
granulomas are the characteristic histologic findings.12
Sarcoid is thought to account for 12%e30% of the cases of
granulomatous liver disease. The granulomas are located
around portal tracts (Fig. 5A) and in mediolobular areas.
Clinically relevant hepatobiliary disease is rare, but, if
present, it is usually related to complications of portal
hypertension or cholestasis.30 The diagnosis of hepatic
sarcoidosis is made based on liver biopsy findings in the
presence of extrahepatic involvement such as pulmonary
sarcoidosis, an elevated angiotensin-converting enzyme
level, and exclusion of infectious causes of hepaticgranulomas. Patients with symptomatic disease or liver
complications can be treated with corticosteroids or urso-
deoxycholic acid. However, therapy is not recommended
for asymptomatic cases of granulomatosis and no evidence
of hepatocellular injury.14,30
PBC
PBC is a progressive autoimmune disease involving inflam-
mation of the intralobular bile ducts with damage of small
intrahepatic bile ducts within the portal tracts (Figs. 6A and
B). The diagnosis can be made by detection of anti-
mitochondrial antibodies, in combination with a character-
istic liver biopsy. On liver biopsy, 25%e50% of patients with
PBC will have granulomas. They are noncaseating and are
located within the portal tracts in close proximity to septal
and interlobular bile ducts. Clinical cholestatic manifesta-
tions are the hallmark of advanced PBC. Medical therapy
for PBC consists of ursodeoxycholic acid, which is used for
its favorable effect on cholestasis, deceleration of liver
disease progression, and prevention of the need for liver
transplantation in cases treated in early stages.31e33
Infectious etiologies
Microorganisms that require a macrophage-based pathway
for clearance may cause granulomas. There are many
infectious causes of hepatic granulomas including myco-
bacterial, viral, fungal and parasitic infections. Patients
with AIDS are especially prone to granulomatous disease
associated with opportunistic infections. Patients who
receive treatment with immunosuppressive medications
such as tumor necrosis factor antagonists are at increased
risk of infectious granulomatous complications. More
common in developing countries are hepatic granulomas
due to leprosy, brucellosis, and Q fever.34,35 Certain
bacterial infections due to agents such as mycobacteria,
Bartonella, brucella, and rickettsia cause predominantly
granulomatous inflammation, while others, such as tula-
remia and listeria, create a mixed suppurative and granu-
lomatous inflammation.36
M tuberculosis
M tuberculosis infection can lead to hepatic granulomas
and less commonly tuberculomas (confluent granulomas
Hepatic granulomatosis 9that form masses) and abscesses involving the liver. Rarely,
tuberculous lymph nodes can compress the porta hepatis
causing biliary tract disease and/or portal hypertension.37
Up to 90% of all patients with miliary tuberculosis have
hepatic granulomas as well as a significant proportion of the
HIV population especially in the developing world.14,38
Classic symptoms of fever, night sweats and weight loss
may be present as well as hepatomegaly and right upper
quadrant pain. Laboratory abnormalities include elevated
bilirubin and aminotransferases with a disproportionately
high alkaline phosphatase.20 On histologic examination,
characteristic epithelioid granulomas (Fig. 1B) and giant
cells are noted, often surrounded by a ring of lymphocytes
and histiocytes and usually without caseation. The latter
are, however, not always universal findings on liver biopsy.
Acid-fast bacilli (AFB) are often seen within the granuloma
as well (Fig. 1C).34 The detection of tuberculosis in patients
with hepatic granulomas may be difficult due to the lack of
caseation necrosis on biopsy or lack of a positive Ziehl-
Neelsen stain or culture. Polymerase chain reaction (PCR)
assay has been reported to detect M tuberculosis with
a sensitivity of 88% and specificity of 100%.39
M bovis
The attenuated strain of M bovis, which is used as a live
vaccine in the form of Bacillus Calmette-Guerin (BCG), as
well as a therapy for bladder cancer or melanoma, can
cause systemic infection. Clinical presentation includes
jaundice; on liver biopsy, hepatic granulomas can be
detected.40
M avium-intracellulare
M avium-intracellulare, an infection common among AIDS
(Figs. 3A and B) patients, can involve the liver in more than
50% of disseminated cases. In these immunocompromised
patients, granulomatous inflammation is composed of
aggregates of foamy macrophages in the parenchyma and
portal tracts, and the organisms can be detected by acid-
fast staining (Figs. 3C and D). Immunocompetent patients,
however, tend to have discrete epithelioid granulomas with
associated neutrophils and lymphocytes without giant cells
or necrosis, and the organism is difficult to detect by acid-
fast stain.41,42
M leprae (leprosy)
M leprae infection can cause lepromatous leprosy in which
more than 60% of patients have hepatic involvement or
tuberculoid leprosy, in which 20% of patients with hepatic
involvement. Aggregates of foamy histiocytes within portal
tracts, and lobules with numerous acid-fast bacilli are
found in lepromatous leprosy, whereas discrete tuberculoid
granulomas with associated giant cells are characteristic of
tuberculoid leprosy in which the bacilli are rarely
detected.43,44
Brucella (brucellosis)
Infections with brucella species can occur as a result of
occupational exposure to livestock, specifically throughinhalation of barnyard dust or by ingestion of their unpas-
teurized products. Clinical presentation includes fever,
malaise, headache, arthralgia, lymphadenopathy, or hep-
atosplenomegaly, in which 50% of cases exhibit hepatic
granulomas on biopsy often with noncaseating granuloma-
tous inflammation. Detection of brucella is difficult and
relies on isolation of brucella from the blood to obtain
a positive serology because it is rarely demonstrated within
the liver.45
Rickettsia and similar species
Infection with Coxiella burnetii, the causative agent of Q
fever, is commonly asymptomatic. However, when there is
hepatic involvement, granulomas can appear as a fibrin ring
of granulomas surrounding a vesicle of fat. This fibrin depo-
sition can also be scattered among epithelioid cells.46 Bou-
tonneuse fever and South African tick bite fever that are
caused by Rickettsia conorii can also cause hepatic granu-
lomas. In these cases, the diagnosis is based on serology.47
Francisella tularensis (tularemia)
Francisella tularensis is a Gram-negative coccobacillus
found in many areas of North America in rodents and
rabbits, which are the vectors for human transmission. With
disseminated infections, hepatic involvement can be
subclinical or may present with elevated aminotransfer-
ases, hepatomegaly, and occasionally jaundice. The histo-
logic picture on liver biopsy is one of suppurative
microabscesses with occasional surrounding macrophages
that may become granulomatous. The diagnosis is based on
serology.48
Listeria monocytogenes (listeriosis)
In neonates or immunocompromised adults, disseminated
listeriosis can involve the liver in the formation of micro-
abscesses with small granulomas. Detection of listeria is
made by blood culture.49
Bartonella henselae (cat scratch disease)
B henselae infection, the causative agent of cat scratch
disease, has been known to cause regional lymphadenitis,
and, in disseminated disease, it can have hepatic involve-
ment. There have been case reports of liver biopsies
showing multiple granulomas with characteristic stellate
abscesses surrounded by three distinct zones: an inner
layer of palisading histiocytes, an intermediate lymphocytic
rim, and an outermost zone of fibrosis. Most cases also have
nonspecific parenchymal changes such as lymphocytic
infiltrates with expanded fibrotic portal triads and dilated
sinusoids surrounding the granulomas.50
Tropheryma whipplei (Whipple disease)
Hepatic involvement with Whipple disease caused by
Tropheryma whipplei is rare. Patients may present with
hepatomegaly and fever in the absence of intestinal
symptoms. Epithelioid granulomas have been reported on
biopsy and diagnosis can be made by Periodic acid-Schiff
(PAS) stain showing positive macrophages.51
Other bacterial infections
Salmonella typhimurium, Rhodococcus equi, which causes
granulomatous patterns similar to Mycobacterium avium-
Figure 7 Schistosomiasis of liver. Note Schistosoma hema-
tobium egg with terminal spine in the center (arrow; H and E,
400).
10 M. Coash et al.intracellulare (MAI), and Pseudomonas pseudomallei
(melioidosis), which causes small neutrophilic micro-
abscesses or granulomas, and chlamydia and syphilis are
examples of other bacterial infections reported to cause
granulomatous hepatitis.20,52,53
Histoplasma capsulatum (histoplasmosis)
Histoplasmosis is the most commonly recognized fungal
disease associated with hepatic granulomatous infection. It
is endemic in the Ohio and Mississippi River valleys. Hepatic
involvement by histoplasmosis manifests with granuloma
formation dominated by macrophages and lymphocytes
with H capsulatum organisms and epithelioid cells located
central to the lesion.54
Other fungal infections
Hepatic candidiasis is characterized by granulomas with
suppurative central areas containing variable necrosis and
giant cells. There may be a histologic appearance to similar
cat scratch disease with palisading histiocytes and a fibrous
scar. Aspergillosis is characterized by a marked neutro-
philic infiltrate or granulomatous inflammation, which is
similar to that in mucormycosis and zygomycetosis. Cryp-
tococcus causes histologic features that range from
necrotizing inflammatory reaction with granulomatous
features in immunocompromised adults to purely granulo-
matous reactions. Occasionally, other fungal infections
such as Pneumocystis carinii, Blastomycosis dermatitidis,
and Paracoccidioides brasiliensis can cause hepatic
granulomas.20,52,55
Schistosomiasis
Infections with Schistosoma mansoni and S japonicum are
frequent in the developing world where waterborne para-
sitic diseases are prevalent. Chronic schistosomiasis causing
granulomas and related fibrosis is the most common cause
of portal hypertension in the world, presenting with
splenomegaly and bleeding.56 The parasites enter the
human host through the skin and circulate until they reach
the mesenteric venules where the produce eggs that are
inadvertently swept by the mesenteric venous blood flow,
eventually lodging in the hepatic sinusoids. Thousands of
eggs can be produced by adult worms. This leads to
a granulomatous reaction rich in eosinophils and is associ-
ated with fibrosis and collagen deposition in the periovular,
periportal, and perisinusoidal areas. This is termed
“pipestem or Symmer fibrosis.” In liver biopsy specimens,
the schistosome eggs (Fig. 7) are commonly found at the
center of the granulomas.56,57 The small branches of the
portal vein become obliterated with subsequent prolifera-
tion of hepatic arterial branches. Presinusoidal portal
hypertension with spreading fibrosis develops, leading to
a grossly nodular appearance of the liver.58
Leishmania donovani (Leishmaniasis)
Visceral leishmaniasis infection with Leishmania donovani or
L infantum is a parasitic infection causing disease in various
intra-abdominal solid organs, and it is often seen in immu-
nocompromised patients with AIDS. Several case reports
have documented fibrin-ring granulomatous hepatitis, which
more commonly occurs with Q fever, Hodgkin disease,
Cytomegalovirus (CMV) hepatitis, and allopurinol treatment.Other studies have noted epithelioid granulomas as well as
hyperplastic Kupffer cells, and organism-filled macro-
phages, forming small nodules or granulomas.59,60
Other parasitic infections
Enterobius vermicularis (pinworm) has been shown in rare
case reports to cause hepatic granulomas consisting of
hyalinized nodules with peripheral inflammation. The
center of the granuloma exhibits necrosis with E vermic-
ularis ova and nematode remnants.61 Fasciola hepatica
infection, fascioliasis, can cause biliary calculi, cholangitis,
obstructive jaundice, and has been shown to cause tumor-
like granulomatous lesions due to transhepatic migration of
the larvae.62 Other rare causes of parasitic granulomatous
hepatitis include Toxoplasma gondii, Capillaria hepatica,
Ascaris lumbricoides, Strongyloides stercoralis, and Giar-
dia lamblia.63e66
Hepatitis C
Retrospective and prospective studies have reported gran-
ulomas in the liver biopsies with a frequency of 1%e10% in
patients with HCV, but no other known systemic or hepatic
diseases. One larger retrospective review described
epithelioid granulomas in 63 of 1662 liver biopsies per-
formed for HCV staging. Antiviral therapy with interferon-
alpha may also contribute to granuloma formation in the
livers of patients with HCV. De novo induction of granu-
lomas can occur with interferon-based therapy as well as
development or activation of subclinical sarcoid due to the
release of cytokines that occurs with enhancement of the
Th1 inflammatory response initiated by the interferon
therapy. Usually the sarcoidosis and granulomas regress
upon cessation of interferon therapy. Granulomatous
disease associated with HCV infection has been linked to
a higher mortality rate.12,38,67e70
Hepatitis B
The data for hepatic granuloma formation in hepatitis B
infection is limited. However, a study by Goldin and
colleagues67 reported hepatic granulomas in 2% (3/151) of
patients with chronic hepatitis B infection. As with hepa-
titis C, it is imperative that other granulomatous diseases
such as tuberculosis, brucellosis, sarcoidosis and drug
reactions be excluded.67
Figure 8 (A) Granulomatous response in liver (black arrow)
associated with a metastatic malignant neoplasm, an islet cell
carcinoma, a neuroendocrine neoplasm (red arrow; H and E,
40); (B) higher power view of the epithelioid granuloma
(arrow; H and E, 400).
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Cytomegalovirus and Epstein-Barr virus can be associated,
although rarely, with epithelioid granulomas in immuno-
competent patients as well as fibrin-ring granulomas. With
Epstein-Barr virus infection, the hepatitis results in
a diffuse lymphocytic sinusoidal infiltrate in a single file
“string of beads” pattern with small Kupffer cell clusters
and discrete noncaseating granulomas.71,72
Drugs and chemicals
Numerous drugs have been implicated in the development
of granulomas in the liver or granulomatous hepatitis. The
overall incidence of drug-induced hepatic granulomas is
thought to be 10%.52 The clinical presentation may be one
of hepatocellular or cholestatic liver injury. Jaundice is
relatively rare. Histology reveals granulomas infiltrated
with eosinophils. Eosinophils in the peripheral blood or
surrounding the granulomas may or may not be present,
and should not be considered to be pathognomic for drug-
induced granulomatous hepatitis.14,52,73 Chemicals such as
beryllium and thorotrast as well as drugs such as phenyl-
butazone, allopurinol, sulfonamides, phenytoin, carba-
mazepine, chlorpropamide, quinidine, methyldopa,
nitrofurantoin, isoniazid, amiodarone, and diazepam
among others have been linked to hepatic granulomas.
There have been several case reports implicating acet-
aminophen, norfloxacin, rosiglitazone, and mesalamine as
culprits as well.13 It may be difficult to establish with
certainty a cause-and-effect relationship between drug
usage and formation of granulomas. However, resolution of
granulomas after discontinuation of the drug may be
helpful in establishing the diagnosis. Other causes should be
ruled out even when patients may have been exposed to
drugs listed above. The management includes discontinu-
ation of the suspected drug with close monitoring of the
clinical course. Repeat liver biopsy may be helpful if the
diagnosis was unclear at the beginning.13
Malignancy
Hodgkin lymphoma, non-Hodgkin lymphoma, and renal cell
carcinoma have all been associated with hepatic granu-
lomas. These types of granulomas are non-necrotic and are
considered to be distinct from malignant cells. The rela-
tionship between malignant lesions and the development of
hepatic granulomas is unclear (Figs. 8A and B). However,
the presence of these granulomas appears to have no
relationship to the prognosis of the tumor.12,74
Idiopathic causes
A substantial proportion of patientsdabout 3%e37%dwith
granulomatous liver disease will never have a cause iden-
tified despite extensive work-up. The term “granulomatous
hepatitis” is often used to refer to a syndrome character-
ized by a prolonged febrile illness, myalgias, hep-
atosplenomegaly, and arthralgias of unclear etiology.
Laboratory work may reveal a markedly elevated sedi-
mentation rate. It is thought that many of these cases may
be related to a subset of autoimmune disease or sarcoid,and some authors have recommended an empirically care-
ful therapeutic trial of corticosteroids or methotrexate.75,76
Others have suggested that an empiric trial of antimicrobial
therapy against M tuberculosis may have benefit in anergic
patients or in those with a positive tuberculin skin test.76 In
other cases where granulomas are an incidental finding
without clinical manifestations or laboratory abnormalities,
periodic monitoring is sufficient.13
Rare causes
Systemic inflammatory and rheumatologic conditions like
Wegener granulomatosis and connective tissue diseases
such as polymyalgia rheumatica, temporal arteritis,
systemic lupus erythematosus, Sjo¨gren disease, and
erythema nodosum have been associated with hepatic
granulomas. Another rare cause is chronic granulomatous
disease, which is a rare inherited disorder caused by
a defect of the reduced nicotinamide adenine dinucleotide
phosphate hydrogen (NADPH) complex leading to loss of the
capacity of macrophages to kill phagocytized bacteria and
12 M. Coash et al.fungi. Although the latter disease is uncommon, 75% of
patients have hepatic granulomas.77,78 Crohn disease and
ulcerative colitis have also been linked to granulomatous
disease in various case reports, although a true association
is unproven. This finding has more specifically been re-
ported in patients with Crohn ileitis.33,79
Conclusion
Although the causes of hepatic granulomatous disease are
numerous, the most common causes include sarcoidosis,
primary biliary cirrhosis, and tuberculosis. Work-up should
include a thorough clinical history, pertinent laboratory
work, and eventually a liver biopsy when this diagnosis is
suspected. Treatment should be focused on the specific
inciting agent with the goal of prevention of complications
such as portal hypertension and liver failure.
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